Q4 2018 Holdings
Filed 2019-02-14 | 137 holdings | $146.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-02-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $93.9M | 1,498,538 | 64.0% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $26.0M | 2,868,221 | 17.7% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $14.1M | 1,911,573 | 9.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $12.0M | 140,542 | 8.2% |
| Amarin | ADR | 023111206 | $70.9K | 5,208,305 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $60.1K | 4,749,623 | 0.0% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $55.8K | 2,038,208 | 0.0% |
| Natera(NTRA) | COMM | 632307104 | $43.3K | 3,100,560 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $42.8K | 2,104,278 | 0.0% |
| Nucana Biomed LtdA | Ordinary Sh | GB00BYWYV | $34.8K | 2,400,000 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $32.9K | 2,266,666 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $27.5K | 1,961,039 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $25.9K | 922,700 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | COMM | 05070R104 | $19.9K | 933,640 | 0.0% |
| Spark Therapeutics | COMM | 84652J103 | $18.8K | 481,270 | 0.0% |
| Sanofi SA(SNY) | ADR | 80105N105 | $14.2K | 327,175 | 0.0% |
| Gilead Sciences Inc(GILD) | COMM | 375558103 | $13.3K | 213,331 | 0.0% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $12.0K | 316,328 | 0.0% |
| Incyte Corp(INCY) | COMM | 45337C102 | $12.0K | 188,497 | 0.0% |
| Tesaro Inc | COMM | 881569107 | $10.0K | 134,297 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $9.3K | 359,713 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $8.9K | 157,984 | 0.0% |
| Iterum Therapeutics | COMM | G6333L101 | $8.7K | 1,726,514 | 0.0% |
| MorphoSys AG | COMM | D55040105 | $8.2K | 80,536 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COMM | 766559603 | $7.8K | 3,382,174 | 0.0% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $7.2K | 199,682 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COMM | 03152W109 | $6.5K | 674,636 | 0.0% |
| Savara Inc(SVRA) | COMM | 805111101 | $5.7K | 754,372 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COMM | 24344T101 | $5.6K | 265,475 | 0.0% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COMM | 45845P108 | $5.5K | 54,472 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COMM | 803607100 | $5.3K | 48,894 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COMM | 189464100 | $5.2K | 287,769 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $5.1K | 1,630,221 | 0.0% |
| Entasis Therapeutics Holdings Inc. | COMM | 293614103 | $4.8K | 1,180,178 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COMM | 64125C109 | $4.4K | 61,500 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $4.2K | 332,921 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COMM | 00900T107 | $4.2K | 175,775 | 0.0% |
| Synlogic Inc. (fmrly Mirna) | COMM | 87166L100 | $4.0K | 574,972 | 0.0% |
| Dermira Inc(DERMEUR) | COMM | 24983L104 | $3.9K | 542,224 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COMM | 74587V107 | $3.9K | 190,627 | 0.0% |
| FibroGen Inc(FGENEUR) | COMM | 31572Q808 | $3.7K | 80,000 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | COMM | G11196105 | $3.6K | 97,445 | 0.0% |
| Orchard Therapeutics PLC | ADR | 68570P101 | $3.5K | 222,618 | 0.0% |
| Epizyme Inc(EPZMEUR) | COMM | 29428V104 | $3.5K | 563,655 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $3.4K | 1,651,172 | 0.0% |
| Foamix Pharmaceuticals Ltd | COMM | M46135105 | $3.0K | 832,293 | 0.0% |
| Fate Therapeutics Inc(FATE) | COMM | 31189P102 | $2.9K | 229,813 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COMM | 33830X104 | $2.9K | 315,344 | 0.0% |
| GW Pharmaceuticals PLC | ADR | 36197T103 | $2.9K | 30,000 | 0.0% |
| Kala Pharmaceuticals Inc | COMM | 483119103 | $2.2K | 445,516 | 0.0% |